Clinical Application Potential of Salivary Microbiome as a Non-Invasive Screening Biomarker for Early Oral Cancer
International Journal of Medical Innovation · 15.05.2026 · 1 (1) · 40-46
DOI: 10.66128/ijmi202601.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Innovation, online erschienen am 28.05.2026. Verfasst von Ke-Zhen Yang und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Oral cancer is a malignant tumor that seriously endangers human health. Early screening is of great significance for improving patient survival rates and quality of life. This study focuses on evaluating the clinical application potential of the salivary microbiome as a non-invasive screening biomarker for early oral cancer, systematically analyzing its real-world research progress.
Methods
By integrating multi-center clinical cohort data, 16S rRNA/ITS1 sequencing technology was used to dynamically monitor microbial community evolution. Simultaneously, an AI-powered salivary detection platform based on surface-enhanced Raman scattering (SERS) was employed, utilizing nanosensors to detect microbial metabolic markers. A LASSO machine learning model was constructed for risk prediction.
Results
The salivary microbial community of patients with oral squamous cell carcinoma showed significant characteristic changes: the α-diversity index decreased by 40% compared to the healthy control group. The abundance of pro-inflammatory genera such as Fusobacterium nucleatum and Streptococcus anginosus increased 3.8-fold, while the abundance of protective genera like Streptococcus salivarius decreased by 67%. Functional analysis indicated significant inhibition of energy related pathways such as the pentose phosphate pathway and pyruvate metabolism, alongside a 2.5-fold increase in the activation rate of the NF-κB inflammatory pathway. Notably, the degree of dysbiosis in mucosal tissue samples was significantly higher than in saliva samples, highlighting the critical value of spatial microbiomics in early diagnosis. At the technological level, the AI-SERS platform enabled parallel detection of microbial metabolic markers, achieving a screening sensitivity of 92.3%, compared to only 78.5% with traditional ELISA, representing a 50% improvement in efficiency and providing technical support for large-scale screening.
Conclusion
This study indicates that the salivary microbiome, as a non-invasive biomarker, holds clear application prospects for the early screening of oral cancer and can play a positive role in improving patient prognosis.
Zitieren
APA
Yang, K., Dong, Y., Wang, Z., Wen, T., Zhang, M., Cui, M., Xu, W., Su, Z., & Guo, Z. (2026). Clinical Application Potential of Salivary Microbiome as a Non-Invasive Screening Biomarker for Early Oral Cancer. International Journal of Medical Innovation, 1(1), 40-46. https://doi.org/10.66128/ijmi202601.4
Vancouver
Yang K, Dong Y, Wang Z, Wen T, Zhang M, Cui M, et al. Clinical Application Potential of Salivary Microbiome as a Non-Invasive Screening Biomarker for Early Oral Cancer. International Journal of Medical Innovation. 2026;1(1):40-46. doi:10.66128/ijmi202601.4
BibTeX
@article{Yang2026,
author = {Yang, Ke-Zhen and Dong, Yu-Lei and Wang, Zheng-Rou and Wen, Tao and Zhang, Miao-Miao and Cui, Ming-Wang and Xu, Wei-Qi and Su, Zhe and Guo, Zhu-Ling},
title = {Clinical Application Potential of Salivary Microbiome as a Non-Invasive Screening Biomarker for Early Oral Cancer},
journal = {International Journal of Medical Innovation},
year = {2026},
volume = {1},
number = {1},
pages = {40--46},
doi = {10.66128/ijmi202601.4}
}
EUVIMED